First-in-human evaluation of 18F-BMS-986327 as a novel PET tracer to assess lysophosphatidic acid receptor 1 (LPA1) target engagement in the lung
R. Smith (Princeton, United States), D. Donnelly (Princeton, United States), J. Gallezot (New Haven, United States), Y. Lu (New Haven, United States), B. Murphy (Princeton, United States), P. Cheng (Princeton, United States), J. Kim (Princeton, United States), E. Charles (Princeton, United States), S. Du (Princeton, United States), D. Holden (New Haven, United States), S. Najafzadeh (New Haven, United States), H. Gao (New Haven, United States), M. Kapinos (New Haven, United States), J. Ropchan (New Haven, United States), N. Nabulsi (New Haven, United States), H. Huang (New Haven, United States), A. Fischer (Princeton, United States), R. Carson (New Haven, United States)
Source: International Congress 2022 – Multimodality respiratory imaging research: what is novel in 2022
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Smith (Princeton, United States), D. Donnelly (Princeton, United States), J. Gallezot (New Haven, United States), Y. Lu (New Haven, United States), B. Murphy (Princeton, United States), P. Cheng (Princeton, United States), J. Kim (Princeton, United States), E. Charles (Princeton, United States), S. Du (Princeton, United States), D. Holden (New Haven, United States), S. Najafzadeh (New Haven, United States), H. Gao (New Haven, United States), M. Kapinos (New Haven, United States), J. Ropchan (New Haven, United States), N. Nabulsi (New Haven, United States), H. Huang (New Haven, United States), A. Fischer (Princeton, United States), R. Carson (New Haven, United States). First-in-human evaluation of 18F-BMS-986327 as a novel PET tracer to assess lysophosphatidic acid receptor 1 (LPA1) target engagement in the lung. 3471
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|